E-LIB Suche - Ergebnisse für: Taskar, Kunal S

1

Development of a physiologically based pharmacokinetic mode..:

Salem, Farzaneh ; Nguyen, Dung ; Bush, Mark...
CPT: Pharmacometrics & Systems Pharmacology. , 2024

2

Physiologically‐based pharmacokinetic modeling of prominent..:

Lewis, Gareth J. ; Ahire, Deepak ; Taskar, Kunal S.
CPT: Pharmacometrics & Systems Pharmacology. 13 (2024) 4 - p. 563-575 , 2024

Link: https://doi.org/10.1002/..

3

Physiologically based pharmacokinetic modeling for developm..:

Salem, Farzaneh ; Nimavardi, Ali ; Mudunuru, Jennypher...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 6 - p. 808-820 , 2023

Link: https://doi.org/10.1002/..

4

Robust physiologically based pharmacokinetic model of rifam..:

Asaumi, Ryuta ; Nunoya, Ken‐ichi ; Yamaura, Yoshiyuki..
CPT: Pharmacometrics & Systems Pharmacology. 11 (2022) 7 - p. 919-933 , 2022

Link: https://doi.org/10.1002/..

5

Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibitio..:

Taskar, Kunal S. ; Yang, Xinning ; Neuhoff, Sibylle...
Clinical Pharmacology & Therapeutics. 112 (2022) 3 - p. 573-592 , 2022

Link: https://doi.org/10.1002/..

6

When special populations intersect with drug–drug interacti..:

Sychterz, Caroline ; Galetin, Aleksandra ; Taskar, Kunal S.
Biopharmaceutics & Drug Disposition. 42 (2021) 4 - p. 160-177 , 2021

Link: https://doi.org/10.1002/..

7

Industrial Perspective on the Benefits Realized From the FD..:

Galluppi, Gerald R. ; Brar, Satjit ; Caro, Luzelena...
Clinical Pharmacology & Therapeutics. 110 (2021) 5 - p. 1172-1175 , 2021

Link: https://doi.org/10.1002/..

8

Intestinal P‐gp and Putative Hepatic OATP1B Induction: Inte..:

Zamek‐Gliszczynski, Maciej J. ; Patel, Mitesh ; Yang, Xinning...
Clinical Pharmacology & Therapeutics. 109 (2020) 1 - p. 55-64 , 2020

Link: https://doi.org/10.1002/..

9

Physiologically‐Based Pharmacokinetic Models for Evaluating..:

Taskar, Kunal S. ; Pilla Reddy, Venkatesh ; Burt, Howard...
Clinical Pharmacology & Therapeutics. 107 (2019) 5 - p. 1082-1115 , 2019

Link: https://doi.org/10.1002/..

10

Can Bile Salt Export Pump Inhibition Testing in Drug Discov..:

Kenna, J. Gerry ; Taskar, Kunal S. ; Battista, Christina...
Clinical Pharmacology & Therapeutics. 104 (2018) 5 - p. 916-932 , 2018

Link: https://doi.org/10.1002/..

11

Unmasking the Role of Uptake Transporters for Digoxin Uptak..:

Taskar, Kunal S ; Mariappan, T Thanga ; Kurawattimath, Vishwanath...
Journal of Central Nervous System Disease. 9 (2017) - p. 117957351769359 , 2017

Link: https://doi.org/10.1177/..

12

Importance of Hepatic Transporters in Clinical Disposition ..:

Patel, Mitesh ; Taskar, Kunal S. ; Zamek‐Gliszczynski, Maciej J.
The Journal of Clinical Pharmacology. 56 (2016) S7 - p. , 2016

Link: https://doi.org/10.1002/..

13

Estimation of the Unbound Brain Concentration of P-Glycopro..:

Mariappan, T. Thanga ; Kurawattimath, Vishwanath ; Gautam, Shashyendra Singh...
Molecular Pharmaceutics. 11 (2014) 2 - p. 477-485 , 2014

Link: https://doi.org/10.1021/..

14

Lapatinib Distribution in HER2 Overexpressing Experimental ..:

Taskar, Kunal S. ; Rudraraju, Vinay ; Mittapalli, Rajendar K....
Pharmaceutical Research. 29 (2011) 3 - p. 770-781 , 2011

Link: https://doi.org/10.1007/..

15

Clinical relevance of hepatic and renal P-gp/BCRP inhibitio..:

Taskar, Kunal S ; Yang, Xinning ; Neuhoff, Sibylle...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436425/. , 2022

Link: http://www.ncbi.nlm.nih...